Increased Activity of Glycerol 3-phosphate Dehydrogenase and Other Lipogenic Enzymes in Human Bladder Cancer

Hormone and Metabolic Research

Volumn 35, Issue 10, 2003, Pages 565-569

  Turyn, J ^a   Schlichtholz, B ^a   Dettlaff Pokora, A ^a   Presler, M ^a   Goyke, E ^a   Matuszewski, M ^a   Kmiec Z ^a   Krajka, K ^a   Swierczynski, J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Bladder cancer; Glycerol 3 phosphate dehydrogenase; Lipogenic enzymes

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE LYASE; CITRATE SYNTHASE; FATTY ACID SYNTHASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; PHOSPHOGLUCONATE DEHYDROGENASE;

ARTICLE; BLADDER CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; LIPOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION; UPREGULATION;

ATP CITRATE (PRO-S)-LYASE; CITRATE (SI)-SYNTHASE; FATTY ACID SYNTHETASE COMPLEX; GLUCOSEPHOSPHATE DEHYDROGENASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE (NAD+); GLYCEROLPHOSPHATE DEHYDROGENASE; HUMANS; LIPIDS; PHOSPHOGLUCONATE DEHYDROGENASE; URINARY BLADDER NEOPLASMS;

EID: 0345448918     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43500     Document Type: Article

References (30)

1. Zelewski M, Swierczynski J. Comparative studies on lipogenic enzyme activities in liver of human and some animal species. Comp Bioch Physiol 1990:95:469-472
2. Kusakabe T, Maeda M, Hoshi N, Sugino T, Watanabe K, Fukuda T, Suzuki T. Fatty Acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and proliferating fetal cells. J Histochem Cytochem 2000; 48: 613-622
3. Swierczynski J, Goyke E, Wach L, Pankiewicz A, Kochan Z, Adamonis W, Sledzinski Z, Aleksandrowicz Z. Comparative study of the lipogenic potential of human and rat adipose tissue. Metabolism 2000; 49: 594-599
4. Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2002; 282: E46-E51
5. Swinnen JV, Vanderhoydonc F, Elgamal AA, Eelen M, Vercaeren I, Joniau S, Van Poppel H, Baert L, Goossens K, Heyns W, Verhoeven G. Selective activation of the fatty acid synthesis pathway in human prostate cancer, Int J Cancer 2000; 88: 176-179
6. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 1996; 77: 474-482
7. Alo PL, Visca P, Framarino ML, Botti C, Monaco S, Sebastiani V, Serpieri DE, Di Tondo U. Immunohistochemical study of fatty acid synthase in ovarian neoplasm. Oncol Rep 2000; 7: 1383-1388
8. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, Kuhajda FP, Hamilton SR. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997; 150: 201-208
9. Pizer ES, Lax SF, Kuhajda FP, Pasternack GR, Kurman RJ. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 1998; 83: 528-537
10. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC, Grizzle WE. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 2000; 31: 1068-1073
11. Krontiras H, Roye GD, Beenken SE, Myers RB, Mayo MS, Peters GE, Grizzle WE. Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue. Head and Neck 1999; 21: 325-329
12. Kuhajda FP, Piantadosi S, Pasternack GR. Haptoglobin-related protein (Hrp) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med 1989; 321: 636-641
13. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994; 91: 6379-6383
14. Jackowski S, Wang J, Baburina I. Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells. Biochim Biophys Acta 2000; 1483: 301-315
15. Jackowski S. Cell cycle regulation of membrane phospholipid metabolism. J Biol Chem 1996; 271: 20219-20222
16. Zolnierowicz S, Swierczynski J, Zelewski L. Isolation and properties of glycerol 3-phosphate oxidoreductase from human placenta. Eur J Biochem 1986; 154: 161-166
17. Swierczynski J, Scislowski PWD, Aleksandrowicz Z, Zydowo MM. Intracellular distribution of fumarase in rat skeletal muscle. Biochim Biophys Acta 1983; 756: 271-278
18. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977; 83: 346-356
19. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580
20. Mayer D, Metzger C, Leonetti P, Beier K, Benner A, Bannasch P. Differential expression of key enzymes of energy metabolism preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int J Cancer 1998; 79: 232-240
21. Brinck U, Eigenbrodt E, Oehmke M, Mazurek S, Fisher G. L-and M2-pyruvate kinase expression in renal cell carcinomas and their metastases. Virchows Arch 1994; 424: 177-185
22. Balabanov S, Zimmermann U, Protzel C, Scharf C, Klebingat KJ, Walther R. Tumor-related enzymes alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur J Biochem 2001; 268: 5977-5980
23. Zampella EJ, Bradley EL Jr., Pretlow TG 2nd. Glucose-6-phosphate dehydrogenase: a possible clinical indicator for prostatic carcinoma. Cancer 1982; 49: 384-387
24. Ledda-Columbano GM, Columbano A, Dessi S, Coni P, Chiodino C, Pani P. Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules. Carcinogenesis 1985; 6: 1371-1373
25. Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. In: Boyer JL, Ockner RK (eds). Progress in liver diseases. Volume XIV. Philadelphia: W. B. Saunders Company, 1996: 161-197
26. Bannash P, Mayer D, Hacker HJ. Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 1980; 605: 217-245
27. Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 2001; 25: 1380-1387
28. Soslow RA, Rouse RV, Hendrickson MR, Silva EG, Longacre TA. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis. Int J Gynecol Pathol 1996; 15: 257-265
29. Dang CH, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999; 24: 68-72
30. Jackowski S. Coordination of membrane phospholipid synthesis with the cell cycle. J Biol Chem 1994; 269: 3858-3867